Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Interest-Expense" stands at 4.22 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2015.
Eisai Co. Ltd.'s second quarter result of 1.44 Billion JPY for the item "Interest Expense" represents an increase of 57.42 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of 1.44 Billion JPY for the item "Interest Expense" represents an increase of 53.90 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of 4.22 Billion JPY for the item "Interest Expense" represents an increase of 13.58 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 45.69 percent compared to the value the year prior.
The 1 year change in percent is 45.69.
The 3 year change in percent is 138.84.
The 5 year change in percent is 182.80.
The 10 year change in percent is 5.26.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Interest Expense | 905,699,262,464.00 |
![]() | Johnson & Johnson - Interest Expense | 486,508,953,600.00 |
![]() | AbbVie Inc - Interest Expense | 399,570,305,024.00 |
![]() | Roche Holding AG - Interest Expense | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Interest Expense | 280,205,508,085.11 |